CEO
Psychiatry
Dr. Michael J. Sernyak Jr., MD
|
|
Give Review
Doctor Michael J. Sernyak Jr., MD is an expert in the field of Psychiatry. He went to Jefferson Medical College. Michael Sernyak is also a published doctor. He has 26 publication published. The most recent publication is: Financial Health and Mental Health Among Clients of a Community Mental Health Center: Making the Connections.
Publications
- Financial Health and Mental Health Among Clients of a Community Mental Health Center: Making the Connections.
- Stakeholders' Perspectives on Community-Based Participatory Research to Enhance Mental Health Services.
- Status of General Medicine Training and Education in Psychiatry Residency.
- The use of second generation antipsychotics for post-traumatic stress disorder in a US Veterans Health Administration Medical Center.
- Prevalence of Concomitant Oral Antipsychotic Drug Use Among Patients Treated With Long-Acting, Intramuscular, Antipsychotic Medications.
- Who is paying the price? Loss of health insurance coverage early in psychosis.
- Duration of pharmacotherapy with long-acting injectable risperidone in the treatment of Schizophrenia.
- Developing a policy for second-generation antipsychotic drugs.
- Antipsychotic use in the treatment of outpatients with Schizophrenia in the VA from fiscal years 1999 to 2006.
- Clinicians' reasons for deviations from recommended dosing practices for antipsychotic medications.
- Identifying metabolic risks with antipsychotics and monitoring and management strategies.
- Generic fluoxetine and choice of antidepressant medication.
- Implementation of monitoring and management guidelines for second-generation antipsychotics.
- Undiagnosed hyperglycemia in patients treated with atypical antipsychotics.
- Predictors of antipsychotic medication change.
- Economic grand rounds: systemwide costs associated with second-generation antipsychotics in the treatment of Schizophrenia.
- Clinicians' reasons for antipsychotic coprescribing.
- Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with Schizophrenia.
- Undiagnosed hyperglycemia in clozapine-treated patients with Schizophrenia.
- Prescribers' nonadherence to treatment guidelines for Schizophrenia when prescribing neuroleptics.
- Use of system-wide outcomes monitoring data to compare the effectiveness of atypical neuroleptic medications.
- Risk adjustment in studies using administrative data.
- Association of diabetes mellitus with use of atypical neuroleptics in the treatment of Schizophrenia.
- Acute tryptophan depletion in schizophrenic patients treated with clozapine.
- Use of second-generation antipsychotic agents for sleep and sedation: a provider survey.
Schools
Thomas Jefferson University
Greenwich Hospital
Yale School Med
Procedures Preformed
- Psychotherapy and Psychophysiological Therapy (incl. Biofeedback)
Conditions Treated
- Schizophrenia
Doctors Specialties
- Psychiatry
Accepted Insurances
Education
-
Yale-New Haven Hospital -
Jefferson Medical College
Helpful Reviews
Similar Doctors
|
|
Dr. James Charney, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Herbert R. Pearsall, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anna Ostrovskaya, MD |
|
|
Dr. Julie A. Chilton, MD |
|
|
Dr. Alejandra Valencia, MD |
|
|
Dr. Robert D. Beech, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neil B. Bruce, MD |
|
|
Dr. Kimberly A. Yonkers, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Albert R. Powers III, MD |
|
|
Dr. Gil Abramovici, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Orlosky, MD |